Regenerative induced pluripotent stem cell therapy (Tenpoint Therapeutics)

N/A

Report date: 2025/04/17 14:38:34

Base Information

Drug NameRegenerative induced pluripotent stem cell therapy (Tenpoint Therapeutics)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Ocular stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsEye Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTenpoint Therapeutics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesTenpoint Therapeutics Ltd

Inactive CompaniesN/A

Active IndicationsEye Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A